Mid-Year Report — TIMMONS AND COMPANY, INC. for TEVA PHARMACEUTICALS USA INC (2007)

Firm

TIMMONS AND COMPANY, INC.

Client

TEVA PHARMACEUTICALS USA INC

Income

$200,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

S. 1695 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. S. 242 - Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251 - Pharmaceutical Market Access Act of 2007 S. 1082 - Prescription Drug User Fee Amendments of 2007 H.R. 2900 - Food and Drug Administration Amendments Act of 2007 S. 28 - To amend title XVIII of the Social Security Act to require the use of generic drugs under the Medicare part D prescription drug program when available unless the brand name drug is determined to be medically necessary. S. 1505 - Affordable Biologics for Consumers Act

Lobbyist	Covered position, as disclosed
MICHAEL J BATES	N/A
BRYCE L HARLOW	N/A
JOHN KELLIHER	N/A
GINGER LOPER	N/A
DANIEL SHAPIRO	DEPUTY COS - OFFICE OF SEN. BILL NELSON
RICHARD J TARPLIN	N/A
WILLIAM E TIMMONS	N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1695 (110th), S. 1082 (110th), S. 251 (110th), S. 1505 (110th), H.R. 2900 (110th), S. 28 (110th), S. 242 (110th)

Budget/Appropriations BUD

H.R. 3161 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008 S. 1859 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008

Lobbyist	Covered position, as disclosed
MICHAEL J BATES	N/A
BRYCE L HARLOW	N/A
JOHN KELLIHER	N/A
GINGER LOPER	N/A
DANIEL SHAPIRO	DEPUTY COS - OFFICE OF SEN. BILL NELSON
RICHARD J TARPLIN	N/A
WILLIAM E TIMMONS	N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1859 (110th), H.R. 3161 (110th)

Copyright/Patent/Trademark CPT

S. 25 - To amend the Federal Food, Drug, and Cosmetic Act to establish requirements for certain petitions submitted to the Food and Drug Administration, and for other purposes. S. 1145 - Patent Reform Act of 2007 H.R. 1908 - Patent Reform Act of 2007

Lobbyist	Covered position, as disclosed
MICHAEL J BATES	N/A
BRYCE L HARLOW	N/A
JOHN KELLIHER	N/A
GINGER LOPER	N/A
DANIEL SHAPIRO	DEPUTY COS - OFFICE OF SEN. BILL NELSON
RICHARD J TARPLIN	N/A
WILLIAM E TIMMONS	N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 25 (110th), H.R. 1908 (110th), S. 1145 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.